Launch Diagnostics' Chris Waghorn tells Pathology in Practice about his company's presence at Congress this year.
Visit www.launchdiagnostics.com for more information.
Launch Diagnostics' Chris Waghorn tells Pathology in Practice about his company's presence at Congress this year.
Visit www.launchdiagnostics.com for more information.
Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...
The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026
Grand Hotel, Birmingham
10 - 11 February, 2026
10 Union Street, London, SE1 1SZ
2 March, 2026
Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026
ICC Belfast, Northern Ireland
13 - 16 April, 2026